News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Renovar Incorporated Presents Data On New Kidney Diagnostic At American Transplant Congress



10/19/2005 5:09:48 PM

MADISON, Wis.--(BUSINESS WIRE)--May 25, 2005--Renovar, Inc., an in vitro diagnostics company, announced results of its new test for kidney transplant patients, at the American Transplantation Congress in Seattle, Washington. The meeting is the Joint Annual Meeting of the American Societies of Transplant Surgeons and Transplantation. The results, presented by Huaizhong Hu, Ph.D., a scientist at the University of Wisconsin and at Renovar, were part of a study conducted by Renovar at the University of Wisconsin-Madison, Division of Transplantation. The Renovar assay, currently under development, is intended to monitor kidney function in transplant patients, based on the identification of key biomarkers in urine. The biomarkers are cytokines, small secreted proteins which mediate and regulate immunity, inflammation and the formation of blood cells.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES